Steven Robert Pacelli Dexcom Inc (DXCM) insider trading activity

Steven Robert Pacelli is EVP Managing Director Dexcom V of DEXCOM INC. Currently has a direct ownership of 124,775 shares of DXCM, which is worth approximately $9.71 Million. The most recent transaction as insider was on Nov 24, 2023, when has been sold 411 shares (Common Stock) at a price of $110.8 per share, resulting in proceeds of $45,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K

0% 3M change

0% 12M change

Total Value Held $9.71 Million

Steven Robert Pacelli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 24 2023	SELL Open market or private sale	$45,538 $110.8 p/Share	411 Reduced 0.33%	124,775 Common Stock
Oct 23 2023	SELL Open market or private sale	$35,243 $85.75 p/Share	411 Reduced 0.33%	125,186 Common Stock
Sep 22 2023	SELL Open market or private sale	$36,332 $88.4 p/Share	411 Reduced 0.33%	125,597 Common Stock
Aug 23 2023	SELL Open market or private sale	$43,989 $107.03 p/Share	411 Reduced 0.33%	126,008 Common Stock
Jul 24 2023	SELL Open market or private sale	$53,798 $130.58 p/Share	412 Reduced 0.32%	126,419 Common Stock
Jul 14 2023	SELL Open market or private sale	$684,216 $136.0 p/Share	5,031 Reduced 3.82%	126,831 Common Stock
Jun 23 2023	SELL Open market or private sale	$51,879 $125.92 p/Share	412 Reduced 0.31%	131,862 Common Stock
May 23 2023	SELL Open market or private sale	$48,883 $118.65 p/Share	412 Reduced 0.31%	132,274 Common Stock
Apr 27 2023	SELL Open market or private sale	$633,906 $126.0 p/Share	5,031 Reduced 3.65%	132,686 Common Stock
Apr 24 2023	SELL Open market or private sale	$51,368 $124.68 p/Share	412 Reduced 0.3%	137,717 Common Stock
Mar 23 2023	SELL Open market or private sale	$633,448 $116.4 p/Share	5,442 Reduced 3.79%	138,129 Common Stock
Mar 10 2023	SELL Sale (or disposition) back to the issuer	$1,299,926 $111.4 p/Share	11,669 Reduced 7.52%	143,571 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	18,776 Added 10.79%	155,240 Common Stock
Feb 23 2023	SELL Open market or private sale	$45,995 $111.64 p/Share	412 Reduced 0.3%	136,464 Common Stock
Jan 23 2023	SELL Open market or private sale	$44,438 $107.86 p/Share	412 Reduced 0.3%	136,876 Common Stock
Dec 23 2022	SELL Open market or private sale	$46,378 $112.57 p/Share	412 Reduced 0.3%	137,288 Common Stock
Aug 23 2022	SELL Open market or private sale	$84,210 $84.21 p/Share	1,000 Reduced 0.72%	137,700 Common Stock
Jul 25 2022	SELL Open market or private sale	$83,070 $83.07 p/Share	1,000 Reduced 0.72%	138,700 Common Stock
Jun 23 2022	SELL Open market or private sale	$72,550 $72.55 p/Share	1,000 Reduced 0.71%	139,700 Common Stock
May 24 2022	SELL Open market or private sale	$74,082 $296.33 p/Share	250 Reduced 0.71%	35,175 Common Stock
Apr 25 2022	SELL Open market or private sale	$109,985 $439.94 p/Share	250 Reduced 0.7%	35,425 Common Stock
Mar 23 2022	SELL Open market or private sale	$114,995 $459.98 p/Share	250 Reduced 0.7%	35,675 Common Stock
Mar 09 2022	SELL Sale (or disposition) back to the issuer	$1,392,380 $406.06 p/Share	3,429 Reduced 8.71%	35,925 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	4,984 Added 11.24%	39,354 Common Stock
Feb 23 2022	SELL Open market or private sale	$98,582 $394.33 p/Share	250 Reduced 0.72%	34,370 Common Stock

Also insider at

OSA

LAAA Merger Corp.

Director

SRP